Bicycle Therapeutics plc
BCYC
$9.69
$0.060.62%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -5.61% | -1.81% | 6.55% | 32.00% | -63.78% |
| Total Depreciation and Amortization | 3.02% | 28.52% | -0.30% | 6.49% | 19.34% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -41.79% | -46.75% | 37.98% | 22.46% | 152.05% |
| Change in Net Operating Assets | 542.06% | -97.16% | -123.00% | -242.38% | -62.43% |
| Cash from Operations | 80.13% | -3,786.05% | -230.89% | -52.70% | -56.02% |
| Capital Expenditure | -621.57% | 13.35% | -51.62% | 99.43% | 96.48% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -621.57% | 13.35% | -51.62% | 99.43% | 96.48% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -36.53% | -- | 4,371.25% | -31.16% | -93.44% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -47.41% | -113.61% | 4,371.25% | -31.16% | -93.44% |
| Foreign Exchange rate Adjustments | -238.17% | 287.71% | -137.87% | -191.83% | -63.73% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 75.16% | -130.36% | 981.91% | -53.13% | -104.63% |
